Gilde Healthcare, a venture capital and private equity firm with more than €2.5bn in invested capital, closed its Gilde Healthcare Venture&Growth VI Fund with €740m ($806.5m) in commitments, building on an initial close in April of €600m ($653.9m).
Finance Watch: Gilde Closes Sixth Venture Fund With €740m For Drugs, MedTech
Cash For Start-Up And Growth-Stage Companies
Private Company Edition: The €740m ($806.5m) Gilde Healthcare Venture&Growth VI Fund will back companies in Europe and North America. Among recent financings, VectorY raised a €129m ($138m) series A round, EyeBio expanded its series A to $130m and MBrace raised an $85m series B.
